nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Dihydrocodeine—CYP3A4—type 2 diabetes mellitus	0.00148	0.152	CrCbGaD
Nalbuphine—Buprenorphine—CYP1A2—type 2 diabetes mellitus	0.00144	0.148	CrCbGaD
Nalbuphine—Oxymorphone—CYP3A4—type 2 diabetes mellitus	0.0013	0.134	CrCbGaD
Nalbuphine—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.00116	0.00151	CcSEcCtD
Nalbuphine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00115	0.00151	CcSEcCtD
Nalbuphine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00115	0.0015	CcSEcCtD
Nalbuphine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00115	0.0015	CcSEcCtD
Nalbuphine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00114	0.00149	CcSEcCtD
Nalbuphine—Flushing—Losartan—type 2 diabetes mellitus	0.00114	0.00148	CcSEcCtD
Nalbuphine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00113	0.00148	CcSEcCtD
Nalbuphine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00148	CcSEcCtD
Nalbuphine—Erythema—Irbesartan—type 2 diabetes mellitus	0.00113	0.00148	CcSEcCtD
Nalbuphine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.00113	0.00148	CcSEcCtD
Nalbuphine—Vision blurred—Metformin—type 2 diabetes mellitus	0.00113	0.00148	CcSEcCtD
Nalbuphine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00113	0.00147	CcSEcCtD
Nalbuphine—Convulsion—Orlistat—type 2 diabetes mellitus	0.00113	0.00147	CcSEcCtD
Nalbuphine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00147	CcSEcCtD
Nalbuphine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00147	CcSEcCtD
Nalbuphine—Tremor—Metformin—type 2 diabetes mellitus	0.00112	0.00147	CcSEcCtD
Nalbuphine—Dizziness—Glipizide—type 2 diabetes mellitus	0.00112	0.00146	CcSEcCtD
Nalbuphine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00112	0.00146	CcSEcCtD
Nalbuphine—Anxiety—Valsartan—type 2 diabetes mellitus	0.00112	0.00146	CcSEcCtD
Nalbuphine—Tension—Irbesartan—type 2 diabetes mellitus	0.00111	0.00145	CcSEcCtD
Nalbuphine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00111	0.00145	CcSEcCtD
Nalbuphine—Anxiety—Orlistat—type 2 diabetes mellitus	0.0011	0.00144	CcSEcCtD
Nalbuphine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.0011	0.00143	CcSEcCtD
Nalbuphine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.0011	0.00143	CcSEcCtD
Nalbuphine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00109	0.00143	CcSEcCtD
Nalbuphine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00109	0.00142	CcSEcCtD
Nalbuphine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00108	0.00141	CcSEcCtD
Nalbuphine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00108	0.0014	CcSEcCtD
Nalbuphine—Syncope—Metformin—type 2 diabetes mellitus	0.00108	0.0014	CcSEcCtD
Nalbuphine—Oedema—Valsartan—type 2 diabetes mellitus	0.00107	0.0014	CcSEcCtD
Nalbuphine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00107	0.0014	CcSEcCtD
Nalbuphine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00107	0.0014	CcSEcCtD
Nalbuphine—Rash—Glipizide—type 2 diabetes mellitus	0.00107	0.00139	CcSEcCtD
Nalbuphine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00107	0.00139	CcSEcCtD
Nalbuphine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00107	0.00139	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00107	0.00139	CcSEcCtD
Nalbuphine—Erythema—Losartan—type 2 diabetes mellitus	0.00107	0.00139	CcSEcCtD
Nalbuphine—Oedema—Orlistat—type 2 diabetes mellitus	0.00106	0.00139	CcSEcCtD
Nalbuphine—Headache—Glipizide—type 2 diabetes mellitus	0.00106	0.00138	CcSEcCtD
Nalbuphine—Tremor—Irbesartan—type 2 diabetes mellitus	0.00106	0.00138	CcSEcCtD
Nalbuphine—Shock—Valsartan—type 2 diabetes mellitus	0.00106	0.00138	CcSEcCtD
Nalbuphine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00105	0.00138	CcSEcCtD
Nalbuphine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.00105	0.00137	CcSEcCtD
Nalbuphine—Tension—Losartan—type 2 diabetes mellitus	0.00105	0.00136	CcSEcCtD
Nalbuphine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00104	0.00136	CcSEcCtD
Nalbuphine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.00104	0.00136	CcSEcCtD
Nalbuphine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00104	0.00136	CcSEcCtD
Nalbuphine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00104	0.00136	CcSEcCtD
Nalbuphine—Agitation—Irbesartan—type 2 diabetes mellitus	0.00104	0.00136	CcSEcCtD
Nalbuphine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00104	0.00136	CcSEcCtD
Nalbuphine—Hypertension—Metformin—type 2 diabetes mellitus	0.00104	0.00135	CcSEcCtD
Nalbuphine—Urticaria—Glyburide—type 2 diabetes mellitus	0.00103	0.00135	CcSEcCtD
Nalbuphine—Oxycodone—CYP3A4—type 2 diabetes mellitus	0.00103	0.107	CrCbGaD
Nalbuphine—Nervousness—Losartan—type 2 diabetes mellitus	0.00103	0.00135	CcSEcCtD
Nalbuphine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00103	0.00134	CcSEcCtD
Nalbuphine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00103	0.00134	CcSEcCtD
Nalbuphine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.00103	0.00134	CcSEcCtD
Nalbuphine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00102	0.00134	CcSEcCtD
Nalbuphine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00102	0.00133	CcSEcCtD
Nalbuphine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.00102	0.00133	CcSEcCtD
Nalbuphine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00102	0.00133	CcSEcCtD
Nalbuphine—Syncope—Irbesartan—type 2 diabetes mellitus	0.00101	0.00132	CcSEcCtD
Nalbuphine—Nausea—Glipizide—type 2 diabetes mellitus	0.00101	0.00131	CcSEcCtD
Nalbuphine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.001	0.00131	CcSEcCtD
Nalbuphine—Hypotension—Valsartan—type 2 diabetes mellitus	0.001	0.00131	CcSEcCtD
Nalbuphine—Vision blurred—Losartan—type 2 diabetes mellitus	0.001	0.00131	CcSEcCtD
Nalbuphine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.001	0.00131	CcSEcCtD
Nalbuphine—Tremor—Losartan—type 2 diabetes mellitus	0.000998	0.0013	CcSEcCtD
Nalbuphine—Rash—Glimepiride—type 2 diabetes mellitus	0.000996	0.0013	CcSEcCtD
Nalbuphine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000995	0.0013	CcSEcCtD
Nalbuphine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000995	0.0013	CcSEcCtD
Nalbuphine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000993	0.0013	CcSEcCtD
Nalbuphine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000992	0.00129	CcSEcCtD
Nalbuphine—Headache—Glimepiride—type 2 diabetes mellitus	0.00099	0.00129	CcSEcCtD
Nalbuphine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000987	0.00129	CcSEcCtD
Nalbuphine—Agitation—Losartan—type 2 diabetes mellitus	0.000979	0.00128	CcSEcCtD
Nalbuphine—Oedema—Metformin—type 2 diabetes mellitus	0.000979	0.00128	CcSEcCtD
Nalbuphine—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000977	0.00128	CcSEcCtD
Nalbuphine—Flushing—Ramipril—type 2 diabetes mellitus	0.000974	0.00127	CcSEcCtD
Nalbuphine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000965	0.00126	CcSEcCtD
Nalbuphine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000964	0.00126	CcSEcCtD
Nalbuphine—Shock—Metformin—type 2 diabetes mellitus	0.000963	0.00126	CcSEcCtD
Nalbuphine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00096	0.00125	CcSEcCtD
Nalbuphine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00096	0.00125	CcSEcCtD
Nalbuphine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000958	0.00125	CcSEcCtD
Nalbuphine—Vertigo—Losartan—type 2 diabetes mellitus	0.000957	0.00125	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000957	0.00125	CcSEcCtD
Nalbuphine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000955	0.00125	CcSEcCtD
Nalbuphine—Syncope—Losartan—type 2 diabetes mellitus	0.000955	0.00125	CcSEcCtD
Nalbuphine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000954	0.00124	CcSEcCtD
Nalbuphine—Buprenorphine—CYP3A4—type 2 diabetes mellitus	0.000953	0.0981	CrCbGaD
Nalbuphine—Naloxone—CYP3A4—type 2 diabetes mellitus	0.000946	0.0974	CrCbGaD
Nalbuphine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000946	0.00124	CcSEcCtD
Nalbuphine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000946	0.00123	CcSEcCtD
Nalbuphine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000942	0.00123	CcSEcCtD
Nalbuphine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000942	0.00123	CcSEcCtD
Nalbuphine—Hydromorphone—CYP3A4—type 2 diabetes mellitus	0.00094	0.0967	CrCbGaD
Nalbuphine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000938	0.00122	CcSEcCtD
Nalbuphine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000936	0.00122	CcSEcCtD
Nalbuphine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000935	0.00122	CcSEcCtD
Nalbuphine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000935	0.00122	CcSEcCtD
Nalbuphine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000935	0.00122	CcSEcCtD
Nalbuphine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000929	0.00121	CcSEcCtD
Nalbuphine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000925	0.00121	CcSEcCtD
Nalbuphine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000925	0.00121	CcSEcCtD
Nalbuphine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000924	0.00121	CcSEcCtD
Nalbuphine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000922	0.0012	CcSEcCtD
Nalbuphine—Hypotension—Metformin—type 2 diabetes mellitus	0.000915	0.00119	CcSEcCtD
Nalbuphine—Erythema—Ramipril—type 2 diabetes mellitus	0.000913	0.00119	CcSEcCtD
Nalbuphine—Shock—Irbesartan—type 2 diabetes mellitus	0.000909	0.00119	CcSEcCtD
Nalbuphine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000906	0.00118	CcSEcCtD
Nalbuphine—Anxiety—Losartan—type 2 diabetes mellitus	0.000904	0.00118	CcSEcCtD
Nalbuphine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000901	0.00118	CcSEcCtD
Nalbuphine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000899	0.00117	CcSEcCtD
Nalbuphine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000898	0.00117	CcSEcCtD
Nalbuphine—Tension—Ramipril—type 2 diabetes mellitus	0.000896	0.00117	CcSEcCtD
Nalbuphine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000894	0.00117	CcSEcCtD
Nalbuphine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000893	0.00117	CcSEcCtD
Nalbuphine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000893	0.00117	CcSEcCtD
Nalbuphine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000887	0.00116	CcSEcCtD
Nalbuphine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000887	0.00116	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000879	0.00115	CcSEcCtD
Nalbuphine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000879	0.00115	CcSEcCtD
Nalbuphine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000878	0.00115	CcSEcCtD
Nalbuphine—Confusional state—Losartan—type 2 diabetes mellitus	0.000876	0.00114	CcSEcCtD
Nalbuphine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000875	0.00114	CcSEcCtD
Nalbuphine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000873	0.00114	CcSEcCtD
Nalbuphine—Somnolence—Metformin—type 2 diabetes mellitus	0.00087	0.00114	CcSEcCtD
Nalbuphine—Oedema—Losartan—type 2 diabetes mellitus	0.000869	0.00113	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000868	0.00113	CcSEcCtD
Nalbuphine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000863	0.00113	CcSEcCtD
Nalbuphine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000862	0.00113	CcSEcCtD
Nalbuphine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000862	0.00112	CcSEcCtD
Nalbuphine—Tremor—Ramipril—type 2 diabetes mellitus	0.000856	0.00112	CcSEcCtD
Nalbuphine—Shock—Losartan—type 2 diabetes mellitus	0.000855	0.00112	CcSEcCtD
Nalbuphine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000854	0.00111	CcSEcCtD
Nalbuphine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00085	0.00111	CcSEcCtD
Nalbuphine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000848	0.00111	CcSEcCtD
Nalbuphine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000847	0.0011	CcSEcCtD
Nalbuphine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000844	0.0011	CcSEcCtD
Nalbuphine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.00084	0.0011	CcSEcCtD
Nalbuphine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00084	0.0011	CcSEcCtD
Nalbuphine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00084	0.0011	CcSEcCtD
Nalbuphine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000839	0.0011	CcSEcCtD
Nalbuphine—Agitation—Ramipril—type 2 diabetes mellitus	0.000839	0.0011	CcSEcCtD
Nalbuphine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000829	0.00108	CcSEcCtD
Nalbuphine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000828	0.00108	CcSEcCtD
Nalbuphine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000828	0.00108	CcSEcCtD
Nalbuphine—Naloxone—ALB—type 2 diabetes mellitus	0.000826	0.085	CrCbGaD
Nalbuphine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000823	0.00107	CcSEcCtD
Nalbuphine—Rash—Glyburide—type 2 diabetes mellitus	0.000821	0.00107	CcSEcCtD
Nalbuphine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000821	0.00107	CcSEcCtD
Nalbuphine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000821	0.00107	CcSEcCtD
Nalbuphine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000821	0.00107	CcSEcCtD
Nalbuphine—Syncope—Ramipril—type 2 diabetes mellitus	0.000819	0.00107	CcSEcCtD
Nalbuphine—Headache—Glyburide—type 2 diabetes mellitus	0.000816	0.00107	CcSEcCtD
Nalbuphine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000813	0.00106	CcSEcCtD
Nalbuphine—Hypotension—Losartan—type 2 diabetes mellitus	0.000812	0.00106	CcSEcCtD
Nalbuphine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000807	0.00105	CcSEcCtD
Nalbuphine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000803	0.00105	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.0008	0.00104	CcSEcCtD
Nalbuphine—Morphine—CYP3A4—type 2 diabetes mellitus	0.000799	0.0822	CrCbGaD
Nalbuphine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000792	0.00103	CcSEcCtD
Nalbuphine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000791	0.00103	CcSEcCtD
Nalbuphine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000782	0.00102	CcSEcCtD
Nalbuphine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000781	0.00102	CcSEcCtD
Nalbuphine—Urticaria—Metformin—type 2 diabetes mellitus	0.000778	0.00101	CcSEcCtD
Nalbuphine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000775	0.00101	CcSEcCtD
Nalbuphine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000775	0.00101	CcSEcCtD
Nalbuphine—Nausea—Glyburide—type 2 diabetes mellitus	0.000774	0.00101	CcSEcCtD
Nalbuphine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000774	0.00101	CcSEcCtD
Nalbuphine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000774	0.00101	CcSEcCtD
Nalbuphine—Somnolence—Losartan—type 2 diabetes mellitus	0.000773	0.00101	CcSEcCtD
Nalbuphine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000771	0.00101	CcSEcCtD
Nalbuphine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000765	0.000999	CcSEcCtD
Nalbuphine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000762	0.000995	CcSEcCtD
Nalbuphine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000761	0.000994	CcSEcCtD
Nalbuphine—Pruritus—Valsartan—type 2 diabetes mellitus	0.00076	0.000993	CcSEcCtD
Nalbuphine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00076	0.000993	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000755	0.000986	CcSEcCtD
Nalbuphine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000752	0.000981	CcSEcCtD
Nalbuphine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000751	0.000981	CcSEcCtD
Nalbuphine—Oedema—Ramipril—type 2 diabetes mellitus	0.000745	0.000973	CcSEcCtD
Nalbuphine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000744	0.000971	CcSEcCtD
Nalbuphine—Rash—Gliclazide—type 2 diabetes mellitus	0.000738	0.000963	CcSEcCtD
Nalbuphine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000737	0.000962	CcSEcCtD
Nalbuphine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000734	0.000958	CcSEcCtD
Nalbuphine—Shock—Ramipril—type 2 diabetes mellitus	0.000733	0.000957	CcSEcCtD
Nalbuphine—Headache—Gliclazide—type 2 diabetes mellitus	0.000733	0.000957	CcSEcCtD
Nalbuphine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.00073	0.000953	CcSEcCtD
Nalbuphine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00073	0.000953	CcSEcCtD
Nalbuphine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000727	0.00095	CcSEcCtD
Nalbuphine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000721	0.000941	CcSEcCtD
Nalbuphine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000716	0.000935	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000711	0.000928	CcSEcCtD
Nalbuphine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000711	0.000928	CcSEcCtD
Nalbuphine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000702	0.000917	CcSEcCtD
Nalbuphine—Asthenia—Metformin—type 2 diabetes mellitus	0.000702	0.000917	CcSEcCtD
Nalbuphine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000696	0.000909	CcSEcCtD
Nalbuphine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000695	0.000907	CcSEcCtD
Nalbuphine—Pruritus—Metformin—type 2 diabetes mellitus	0.000692	0.000904	CcSEcCtD
Nalbuphine—Urticaria—Losartan—type 2 diabetes mellitus	0.000691	0.000901	CcSEcCtD
Nalbuphine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000687	0.000897	CcSEcCtD
Nalbuphine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000687	0.000897	CcSEcCtD
Nalbuphine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000683	0.000892	CcSEcCtD
Nalbuphine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000681	0.000888	CcSEcCtD
Nalbuphine—Rash—Valsartan—type 2 diabetes mellitus	0.000678	0.000885	CcSEcCtD
Nalbuphine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000677	0.000884	CcSEcCtD
Nalbuphine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000675	0.000881	CcSEcCtD
Nalbuphine—Headache—Valsartan—type 2 diabetes mellitus	0.000673	0.000879	CcSEcCtD
Nalbuphine—Rash—Orlistat—type 2 diabetes mellitus	0.00067	0.000874	CcSEcCtD
Nalbuphine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000669	0.000874	CcSEcCtD
Nalbuphine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000669	0.000873	CcSEcCtD
Nalbuphine—Headache—Orlistat—type 2 diabetes mellitus	0.000665	0.000868	CcSEcCtD
Nalbuphine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000665	0.000867	CcSEcCtD
Nalbuphine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000663	0.000865	CcSEcCtD
Nalbuphine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000663	0.000865	CcSEcCtD
Nalbuphine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000656	0.000856	CcSEcCtD
Nalbuphine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000653	0.000853	CcSEcCtD
Nalbuphine—Dizziness—Metformin—type 2 diabetes mellitus	0.000647	0.000845	CcSEcCtD
Nalbuphine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00064	0.000836	CcSEcCtD
Nalbuphine—Nausea—Valsartan—type 2 diabetes mellitus	0.000638	0.000833	CcSEcCtD
Nalbuphine—Nausea—Orlistat—type 2 diabetes mellitus	0.000631	0.000823	CcSEcCtD
Nalbuphine—Asthenia—Losartan—type 2 diabetes mellitus	0.000624	0.000814	CcSEcCtD
Nalbuphine—Vomiting—Metformin—type 2 diabetes mellitus	0.000622	0.000812	CcSEcCtD
Nalbuphine—Rash—Metformin—type 2 diabetes mellitus	0.000617	0.000806	CcSEcCtD
Nalbuphine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000617	0.000805	CcSEcCtD
Nalbuphine—Pruritus—Losartan—type 2 diabetes mellitus	0.000615	0.000803	CcSEcCtD
Nalbuphine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000614	0.000802	CcSEcCtD
Nalbuphine—Headache—Metformin—type 2 diabetes mellitus	0.000613	0.0008	CcSEcCtD
Nalbuphine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000611	0.000797	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000609	0.000796	CcSEcCtD
Nalbuphine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000592	0.000773	CcSEcCtD
Nalbuphine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000589	0.000769	CcSEcCtD
Nalbuphine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000589	0.000769	CcSEcCtD
Nalbuphine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000587	0.000767	CcSEcCtD
Nalbuphine—Rash—Irbesartan—type 2 diabetes mellitus	0.000582	0.00076	CcSEcCtD
Nalbuphine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000582	0.000759	CcSEcCtD
Nalbuphine—Nausea—Metformin—type 2 diabetes mellitus	0.000581	0.000759	CcSEcCtD
Nalbuphine—Headache—Irbesartan—type 2 diabetes mellitus	0.000579	0.000755	CcSEcCtD
Nalbuphine—Dizziness—Losartan—type 2 diabetes mellitus	0.000575	0.00075	CcSEcCtD
Nalbuphine—Vomiting—Losartan—type 2 diabetes mellitus	0.000553	0.000721	CcSEcCtD
Nalbuphine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000549	0.000717	CcSEcCtD
Nalbuphine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000549	0.000716	CcSEcCtD
Nalbuphine—Rash—Losartan—type 2 diabetes mellitus	0.000548	0.000715	CcSEcCtD
Nalbuphine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000548	0.000715	CcSEcCtD
Nalbuphine—Headache—Losartan—type 2 diabetes mellitus	0.000545	0.000711	CcSEcCtD
Nalbuphine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000535	0.000698	CcSEcCtD
Nalbuphine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000527	0.000688	CcSEcCtD
Nalbuphine—Nausea—Losartan—type 2 diabetes mellitus	0.000516	0.000674	CcSEcCtD
Nalbuphine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000493	0.000643	CcSEcCtD
Nalbuphine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000474	0.000619	CcSEcCtD
Nalbuphine—Rash—Ramipril—type 2 diabetes mellitus	0.00047	0.000613	CcSEcCtD
Nalbuphine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00047	0.000613	CcSEcCtD
Nalbuphine—Headache—Ramipril—type 2 diabetes mellitus	0.000467	0.000609	CcSEcCtD
Nalbuphine—Nausea—Ramipril—type 2 diabetes mellitus	0.000443	0.000578	CcSEcCtD
Nalbuphine—OPRD1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000132	0.000589	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000132	0.000588	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000132	0.000587	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000131	0.000586	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000131	0.000585	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000131	0.000584	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.00013	0.000581	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000129	0.000576	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000127	0.000565	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000127	0.000565	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000126	0.000563	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000126	0.000561	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000125	0.000559	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000125	0.000556	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000124	0.000553	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000122	0.000544	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000122	0.000544	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000122	0.000543	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000122	0.000543	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.00012	0.000537	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.00012	0.000535	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000119	0.000531	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000118	0.000528	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000118	0.000528	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000118	0.000526	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000118	0.000526	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000118	0.000526	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000118	0.000524	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000117	0.000521	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000116	0.000517	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000116	0.000517	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000116	0.000517	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000116	0.000517	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000115	0.000515	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000115	0.000515	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000115	0.000515	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000115	0.000515	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000115	0.000512	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000114	0.000509	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000114	0.000509	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000113	0.000505	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000113	0.000503	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000113	0.000503	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000113	0.000502	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000113	0.000502	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000112	0.0005	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000111	0.000495	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000111	0.000494	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000111	0.000494	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.00011	0.000491	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000107	0.000479	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000107	0.000478	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000107	0.000477	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000107	0.000477	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000107	0.000476	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000107	0.000476	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000106	0.000471	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000106	0.000471	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000105	0.00047	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000105	0.000469	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000104	0.000463	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000104	0.000463	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000104	0.000462	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000103	0.000461	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000103	0.000461	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000103	0.00046	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000102	0.000454	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000102	0.000453	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000101	0.000451	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000101	0.000451	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000101	0.000449	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.0001	0.000446	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.0001	0.000446	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INSR—type 2 diabetes mellitus	9.94e-05	0.000443	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	9.88e-05	0.000441	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	9.79e-05	0.000437	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	9.76e-05	0.000435	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	9.75e-05	0.000435	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.72e-05	0.000434	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	9.7e-05	0.000433	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	9.7e-05	0.000433	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	9.7e-05	0.000433	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	9.57e-05	0.000427	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	9.41e-05	0.00042	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	9.37e-05	0.000418	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	9.36e-05	0.000417	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	9.29e-05	0.000415	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GCG—type 2 diabetes mellitus	9.26e-05	0.000413	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	9.26e-05	0.000413	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.18e-05	0.00041	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	9.11e-05	0.000406	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.1e-05	0.000406	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	9.08e-05	0.000405	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	9.05e-05	0.000403	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.02e-05	0.000402	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.02e-05	0.000402	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.98e-05	0.0004	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AVP—type 2 diabetes mellitus	8.98e-05	0.0004	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.94e-05	0.000399	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.9e-05	0.000397	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	8.89e-05	0.000397	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.81e-05	0.000393	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.78e-05	0.000392	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.74e-05	0.00039	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.74e-05	0.00039	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOB—type 2 diabetes mellitus	8.67e-05	0.000387	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.66e-05	0.000386	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.64e-05	0.000385	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.59e-05	0.000383	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.55e-05	0.000382	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.55e-05	0.000382	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EDN1—type 2 diabetes mellitus	8.54e-05	0.000381	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.51e-05	0.00038	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.5e-05	0.000379	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.45e-05	0.000377	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LPL—type 2 diabetes mellitus	8.28e-05	0.000369	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.21e-05	0.000366	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.11e-05	0.000362	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.05e-05	0.000359	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.98e-05	0.000356	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.96e-05	0.000355	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.92e-05	0.000353	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AVP—type 2 diabetes mellitus	7.87e-05	0.000351	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.87e-05	0.000351	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.84e-05	0.00035	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.82e-05	0.000349	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	7.82e-05	0.000349	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.8e-05	0.000348	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.77e-05	0.000347	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.72e-05	0.000344	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.7e-05	0.000343	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.67e-05	0.000342	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.63e-05	0.00034	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOB—type 2 diabetes mellitus	7.61e-05	0.000339	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.58e-05	0.000338	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.49e-05	0.000334	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—C3—type 2 diabetes mellitus	7.46e-05	0.000333	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.32e-05	0.000327	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.26e-05	0.000324	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.19e-05	0.000321	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.19e-05	0.000321	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.11e-05	0.000317	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.11e-05	0.000317	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.09e-05	0.000316	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.09e-05	0.000316	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.97e-05	0.000311	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.94e-05	0.00031	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.94e-05	0.00031	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.86e-05	0.000306	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.81e-05	0.000304	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.81e-05	0.000304	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.74e-05	0.000301	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.69e-05	0.000299	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.65e-05	0.000297	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.65e-05	0.000297	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.62e-05	0.000295	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.59e-05	0.000294	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.55e-05	0.000292	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—C3—type 2 diabetes mellitus	6.54e-05	0.000292	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.53e-05	0.000291	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.43e-05	0.000287	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.4e-05	0.000286	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.33e-05	0.000282	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.24e-05	0.000278	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.22e-05	0.000278	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.21e-05	0.000277	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.19e-05	0.000276	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.14e-05	0.000274	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.11e-05	0.000273	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.09e-05	0.000272	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.09e-05	0.000272	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.02e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.01e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—INS—type 2 diabetes mellitus	5.93e-05	0.000265	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.84e-05	0.00026	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.76e-05	0.000257	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.74e-05	0.000256	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.74e-05	0.000256	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.73e-05	0.000256	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.71e-05	0.000255	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.66e-05	0.000252	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	5.53e-05	0.000247	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.45e-05	0.000243	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.43e-05	0.000242	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.27e-05	0.000235	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.26e-05	0.000235	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.25e-05	0.000234	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.2e-05	0.000232	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.2e-05	0.000232	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	5.2e-05	0.000232	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.16e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.15e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.15e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.12e-05	0.000228	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.09e-05	0.000227	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.03e-05	0.000224	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.03e-05	0.000224	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.01e-05	0.000223	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.9e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.85e-05	0.000216	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.78e-05	0.000213	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.59e-05	0.000205	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.56e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.56e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.46e-05	0.000199	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.42e-05	0.000197	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	4.4e-05	0.000196	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.39e-05	0.000196	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.32e-05	0.000193	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.29e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.25e-05	0.00019	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.25e-05	0.00019	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.23e-05	0.000189	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.17e-05	0.000186	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.13e-05	0.000184	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.05e-05	0.000181	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.04e-05	0.00018	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.91e-05	0.000174	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.87e-05	0.000173	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.85e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.85e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.85e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.85e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.75e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.66e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.63e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.62e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.55e-05	0.000158	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.44e-05	0.000153	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.37e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.37e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.3e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.29e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.27e-05	0.000146	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.25e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.09e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.06e-05	0.000136	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.02e-05	0.000135	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.96e-05	0.000132	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.85e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.78e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.59e-05	0.000116	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.55e-05	0.000114	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.5e-05	0.000111	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.39e-05	0.000107	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.27e-05	0.000101	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.1e-05	9.35e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.92e-05	8.57e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.77e-05	7.9e-05	CbGpPWpGaD
